Multidisciplinary cost-containment program promoting less frequent administration of injectable mezlocillin.

Simple item page
dc.contributor.authorBriceland, Laurie L
dc.contributor.authorNightingale, C H
dc.contributor.authorQuintiliani, R
dc.contributor.authorCooper, B W
dc.contributor.orcidhttps://orcid.org/0000-0001-7013-7318
dc.date.accessioned2023-11-03T19:00:01Z
dc.date.available2023-11-03T19:00:01Z
dc.date.issued1988-05
dc.descriptionClick on the Resource Link to access the article (may not be free).
dc.description.abstractA multidisciplinary cost-containment program for promoting less frequent administration of mezlocillin injection is described. The pharmacy department and the division of infectious diseases at Hartford Hospital implemented a program through which regimens of mezlocillin 5 g every eight hours would automatically be substituted for the frequently prescribed regimen of mezlocillin 3 g every four hours. Patients with urinary-tract infections or renal insufficiency and febrile neutropenic cancer patients also received various modified regimens. Use of the modified regimens was promoted through inservice education programs and distribution of newsletters and pocket-size brochures describing the dose-dependent pharmacokinetics of mezlocillin to medical staff. The pharmacy and therapeutics committee supported the program by endorsing the use of the modified regimens and distributing periodic progress reports. Pharmacists on the nursing units were responsible for enforcing the program stipulations regarding modified dosage regimens and for reporting adverse reactions and unexpected therapeutic failures. Ten months after implementation of the program, there was better than 99% compliance with the appropriately modified mezlocillin dosage regimens. Theoretical annual cost savings based on less frequent administration of mezlocillin injection amount to more than $33,000. The multidisciplinary program described here was successful in promoting the use of modified mezlocillin dosage regimens.
dc.description.urihttps://doi.org/10.1093/ajhp/45.5.1082
dc.identifier.citationBriceland LL, Nightingale CH, Quintiliani R, Cooper BW. Multidisciplinary cost-containment program promoting less frequent administration of injectable mezlocillin. Am J Hosp Pharm. 1988 May;45(5):1082-5. PMID: 3400649.
dc.identifier.issn0002-9289
dc.identifier.other3400649
dc.identifier.urihttps://hdl.handle.net/20.500.14303/244
dc.language.isoen
dc.publisherAmerican Society Of Hospital Pharmacists
dc.relation.ispartofAmerican Journal of Health-System Pharmacy : AJHP
dc.rightsThis Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). http://rightsstatements.org/vocab/InC/1.0/
dc.subjectMedication Systems, Hospital / economics
dc.subjectMezlocillin / administration & dosage
dc.titleMultidisciplinary cost-containment program promoting less frequent administration of injectable mezlocillin.
dc.typeArticle
local.departmentprogramDepartment of Pharmacy Practice
Files
Collections
Briceland, Laurie Publications